Showing 1 - 2 results of 2 for search 'Liubao Peng', query time: 0.01s Refine Results
  1. 1
    Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA

    Cost-effectiveness analysis of pembrolizumab plus chemotherapy for previously untreated metastatic non-small cell lung cancer in the USA by Xiaohui Zeng, Xiaomin Wan, Liubao Peng, Ye Peng, Fang Ma, Qiao Liu, Chongqing Tan

    Published 2019-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China

    Cost-effectiveness analysis of adding ramucirumab to the first-line erlotinib treatment for untreated EGFR-mutated metastatic non-small cell lung cancer in China by Xiaohui Zeng, Xiaomin Wan, Liubao Peng, Qiao Liu, Chongqing Tan, Xia Luo, Lidan Yi

    Published 2020-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: